BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34382511)

  • 61. Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2.
    Anelli V; Gault CR; Cheng AB; Obeid LM
    J Biol Chem; 2008 Feb; 283(6):3365-3375. PubMed ID: 18055454
    [TBL] [Abstract][Full Text] [Related]  

  • 62. AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells.
    Coant N; García-Barros M; Zhang Q; Obeid LM; Hannun YA
    Oncogene; 2018 Jul; 37(28):3852-3863. PubMed ID: 29662189
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of ceramide glucosylation sensitizes lung cancer cells to ABC294640, a first-in-class small molecule SphK2 inhibitor.
    Guan S; Liu YY; Yan T; Zhou J
    Biochem Biophys Res Commun; 2016 Aug; 476(4):230-236. PubMed ID: 27221045
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties.
    Pitman MR; Powell JA; Coolen C; Moretti PA; Zebol JR; Pham DH; Finnie JW; Don AS; Ebert LM; Bonder CS; Gliddon BL; Pitson SM
    Oncotarget; 2015 Mar; 6(9):7065-83. PubMed ID: 25788259
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dimethylsphingosine and FTY720 inhibit the SK1 form but activate the SK2 form of sphingosine kinase from rat heart.
    Vessey DA; Kelley M; Zhang J; Li L; Tao R; Karliner JS
    J Biochem Mol Toxicol; 2007; 21(5):273-9. PubMed ID: 17912702
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma.
    Salama MF; Carroll B; Adada M; Pulkoski-Gross M; Hannun YA; Obeid LM
    FASEB J; 2015 Jul; 29(7):2803-13. PubMed ID: 25805832
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury.
    Park SW; Kim M; Brown KM; D'Agati VD; Lee HT
    J Am Soc Nephrol; 2012 Feb; 23(2):266-80. PubMed ID: 22095950
    [TBL] [Abstract][Full Text] [Related]  

  • 68. FTY720 (Fingolimod) attenuates basal and sphingosine-1-phosphate-evoked thyroid cancer cell invasion.
    Kalhori V; Magnusson M; Asghar MY; Pulli I; Törnquist K
    Endocr Relat Cancer; 2016 May; 23(5):457-68. PubMed ID: 26935838
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis.
    Maceyka M; Payne SG; Milstien S; Spiegel S
    Biochim Biophys Acta; 2002 Dec; 1585(2-3):193-201. PubMed ID: 12531554
    [TBL] [Abstract][Full Text] [Related]  

  • 70. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
    Mu Y; Zou H; Chen B; Fan Y; Luo S
    Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sanguinarine triggers intrinsic apoptosis to suppress colorectal cancer growth through disassociation between STRAP and MELK.
    Gong X; Chen Z; Han Q; Chen C; Jing L; Liu Y; Zhao L; Yao X; Sun X
    BMC Cancer; 2018 May; 18(1):578. PubMed ID: 29783958
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.
    Oaks JJ; Santhanam R; Walker CJ; Roof S; Harb JG; Ferenchak G; Eisfeld AK; Van Brocklyn JR; Briesewitz R; Saddoughi SA; Nagata K; Bittman R; Caligiuri MA; Abdel-Wahab O; Levine R; Arlinghaus RB; Quintas-Cardama A; Goldman JM; Apperley J; Reid A; Milojkovic D; Ziolo MT; Marcucci G; Ogretmen B; Neviani P; Perrotti D
    Blood; 2013 Sep; 122(11):1923-34. PubMed ID: 23926298
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells.
    Loveridge C; Tonelli F; Leclercq T; Lim KG; Long JS; Berdyshev E; Tate RJ; Natarajan V; Pitson SM; Pyne NJ; Pyne S
    J Biol Chem; 2010 Dec; 285(50):38841-52. PubMed ID: 20926375
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells.
    von Haefen C; Wieder T; Gillissen B; Stärck L; Graupner V; Dörken B; Daniel PT
    Oncogene; 2002 Jun; 21(25):4009-19. PubMed ID: 12037683
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.
    Gault CR; Obeid LM
    Crit Rev Biochem Mol Biol; 2011 Aug; 46(4):342-51. PubMed ID: 21787121
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.
    Cianchi F; Papucci L; Schiavone N; Lulli M; Magnelli L; Vinci MC; Messerini L; Manera C; Ronconi E; Romagnani P; Donnini M; Perigli G; Trallori G; Tanganelli E; Capaccioli S; Masini E
    Clin Cancer Res; 2008 Dec; 14(23):7691-700. PubMed ID: 19047095
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.
    Huwiler A; Pfeilschifter J
    Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synthesis of PP2A-Activating PF-543 Derivatives and Investigation of Their Inhibitory Effects on Pancreatic Cancer Cells.
    Kim SB; Oh YS; Kim KJ; Cho SW; Park SK; Baek DJ; Park EY
    Molecules; 2022 May; 27(10):. PubMed ID: 35630821
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sphingosine kinase 1 downregulation is required for adaptation to serine deprivation.
    Truman JP; Ruiz CF; Trayssac M; Mao C; Hannun YA; Obeid LM
    FASEB J; 2021 Feb; 35(2):e21284. PubMed ID: 33484475
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer.
    Kang JH; Jang JE; Mishra SK; Lee HJ; Nho CW; Shin D; Jin M; Kim MK; Choi C; Oh SH
    J Ethnopharmacol; 2015 Sep; 173():303-12. PubMed ID: 26210065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.